The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Astor Andrew since 2017.
This trader's CIK number is 1698052.
At the time of last reporting, Astor Andrew was the President, CEO & CFO of Nephros Inc. (stock ticker symbol NEPH).
Also see all insider trading activities at Nephros Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | NEPH | 0 | $0 | 0 | $0 | 14,815 | $40,000 |
| 2021 | NEPH | 5,000 | $38,604 | 0 | $0 | 0 | $0 |
| 2020 | NEPH | 4,650 | $32,476 | 0 | $0 | 0 | $0 |
| 2019 | NEPH | 37,250 | $39,137 | 0 | $0 | 0 | $0 |
| 2018 | NEPH | 85,000 | $38,375 | 0 | $0 | 0 | $0 |
| 2017 | NEPH | 214,999 | $17,076 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-05 | NEPH | Option Ex | 14,815 | 2.70 | 40,000 |
| 2021-08-17 | NEPH | Buy | 2,500 | 7.67 | 19,172 |
| 2021-08-18 | NEPH | Buy | 2,500 | 7.77 | 19,432 |
| 2020-11-19 | NEPH | Buy | 1,000 | 5.87 | 5,867 |
| 2020-08-19 | NEPH | Buy | 950 | 7.40 | 7,030 |
| 2020-05-28 | NEPH | Buy | 1,000 | 6.96 | 6,960 |
| 2020-03-12 | NEPH | Buy | 1,000 | 6.70 | 6,700 |
| 2020-03-05 | NEPH | Buy | 700 | 8.46 | 5,919 |
| 2019-11-18 | NEPH | Buy | 750 | 8.38 | 6,282 |
| 2019-08-22 | NEPH | Buy | 1,500 | 6.97 | 10,455 |
| 2019-06-14 | NEPH | Buy | 35,000 | .64 | 22,400 |
| 2018-04-10 | NEPH | Buy | 80,000 | .45 | 36,000 |
| 2018-03-09 | NEPH | Buy | 5,000 | .47 | 2,375 |
| 2017-12-01 | NEPH | Buy | 10,000 | .50 | 5,000 |
| 2017-12-04 | NEPH | Buy | 8,333 | .50 | 4,166 |
| 2017-08-28 | NEPH | Buy | 10,000 | .27 | 2,710 |
| 2017-08-11 | NEPH | Buy | 20,000 | .26 | 5,200 |
| 2017-03-17 | NEPH | Buy | 166,666 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Astor Andrew (President, CEO & CFO of Nephros Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.